| Identification | Back Directory | [Name]
( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) | [CAS]
475084-96-9 | [Synonyms]
Selexipag Impurity 8
TUQMNTRUQSTQNJ-UHFFFAOYSA-N
4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]-1-butanol
tert-butyl 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetate
[4-[(5,6-Diphenylpyrazinyl)(1-methylethyl)amino]butoxy]acetic acid 1,1-dimethylethyl ester
( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester )
Acetic acid, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-, 1,1-dimethylethyl ester | [Molecular Formula]
C29H37N3O3 | [MOL File]
475084-96-9.mol | [Molecular Weight]
475.62 |
| Hazard Information | Back Directory | [Uses]
2-{4-[N-(5,6-Diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester is an impurity of Selexipag (S253150), an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans. |
|
|